Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2002 Clinician and Researcher, Commentary 2 Matthew Wynia, MD, MPH An ethical case involves a non-academic physician who is considering being a clinical investigator for an industry-sponsored Phase III clinical trial. Virtual Mentor. 2002;4(10):292-295. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210. Case and Commentary Oct 2002 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD An ethical case involves a non-academic physician who is considering being a clinical investigator for an industry-sponsored Phase III clinical trial. Virtual Mentor. 2002;4(10):288-291. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210. In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients. Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12
Case and Commentary Oct 2002 Clinician and Researcher, Commentary 2 Matthew Wynia, MD, MPH An ethical case involves a non-academic physician who is considering being a clinical investigator for an industry-sponsored Phase III clinical trial. Virtual Mentor. 2002;4(10):292-295. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210.
Case and Commentary Oct 2002 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD An ethical case involves a non-academic physician who is considering being a clinical investigator for an industry-sponsored Phase III clinical trial. Virtual Mentor. 2002;4(10):288-291. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210.
In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients. Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.